Traci Green
Staff Affiliate - YNHHAbout
Research
Publications
2025
Point‐Of‐Care Drug‐Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances
Ujeneza M, Tardif J, Thompson E, Badea A, Morales A, Altomare‐Jarczyk C, Green T, Serafinski R, McKenzie M, Park J. Point‐Of‐Care Drug‐Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances. Drug And Alcohol Review 2025 PMID: 40977066, DOI: 10.1111/dar.70037.Peer-Reviewed Original ResearchDrug categoriesLC-QTOF-MSPresence of cocaineDrug supplyLiquid chromatography-quadrupole time-of-flight mass spectrometryHarm reduction sitesHarm reduction educationCocaineTime-of-flight mass spectrometryFentanylOverdose riskReal-time FTIRFourier transform infrared (FTIR) spectroscopyDrug checking servicesService usersInfrared (FTIR) spectroscopyIllicit drug supplyReduction educationSemi-quantitative testDrugReduction siteXylazine Awareness and Suspected Presence in the Illicit Drug Supply Among People Who Used Stimulants in an Overdose Hotspot, 2023
Kelly P, Green T, Rich J, Vento S, Bailey A, Silva V, Noh M, Hughto J. Xylazine Awareness and Suspected Presence in the Illicit Drug Supply Among People Who Used Stimulants in an Overdose Hotspot, 2023. Substance Use & Misuse 2025, ahead-of-print: 1-10. PMID: 40888200, DOI: 10.1080/10826084.2025.2549501.Peer-Reviewed Original ResearchNon-HispanicPurposive sub-sampleBlack non-HispanicSubstance useNon-Hispanic participantsPercentage of participantsHigh school degreeIn-depth interviewsHarm-reduction messagesLiteracy-appropriateChi-square testLess educationTrusted messengersReduction messagesSurvey participantsSchool degreeCollege educationQualitative dataChi-squareIllicit drug supplyParticipantsOpioid useDrug supplyEffects of xylazineUse experienceKey-Informant Perspectives On Pharmacy-Based Methadone Treatment For Opioid Use Disorder In The US
Stewart M, Feltus S, Tschampl C, Bratberg J, Green T. Key-Informant Perspectives On Pharmacy-Based Methadone Treatment For Opioid Use Disorder In The US. Health Affairs 2025, 44: 1164-1172. PMID: 40893075, DOI: 10.1377/hlthaff.2025.00344.Peer-Reviewed Original ResearchCorrection: Developing a comprehensive inventory to define harm reduction housing
Zaragoza S, Silcox J, Rapisarda S, Summers C, Case P, To C, Chatterjee A, Walley A, Komaromy M, Green T. Correction: Developing a comprehensive inventory to define harm reduction housing. Harm Reduction Journal 2025, 22: 142. PMID: 40826084, PMCID: PMC12363098, DOI: 10.1186/s12954-025-01290-0.Peer-Reviewed Original ResearchAmputation trends among people who use drugs in the context of Philadelphia’s increasingly xylazine adulterated drug supply
Laurano R, Pogorzelska-Maziarz M, Green T, Beachy S, Rising K, Hom J, Reed M. Amputation trends among people who use drugs in the context of Philadelphia’s increasingly xylazine adulterated drug supply. Drug And Alcohol Dependence 2025, 275: 112826. PMID: 40815910, DOI: 10.1016/j.drugalcdep.2025.112826.Peer-Reviewed Original ResearchInternational ClassificationFactors associated with amputationAssociated with amputationInternational Classification of DiseasesAcute care visitsIncidence of amputationClassification of diseasesDrug supplyTreatment completionMultivariate logistic regressionActive substance useCare visitsHealth providersRetrospective analysis of dataICD-10United StatesUnique patientsLogistic regressionAmputationDrug checkingOpioid related disordersOverdose deathsAnalysis of dataMedical examinationSubstance use“Anything can happen”: experiences of people using opioids in a xylazine market
Reed M, Martin González K, Green T, Esteves Camacho T, Laurano R, Clark-García F, Geraci C, Kane A, Rising K. “Anything can happen”: experiences of people using opioids in a xylazine market. Harm Reduction Journal 2025, 22: 134. PMID: 40745293, PMCID: PMC12312578, DOI: 10.1186/s12954-025-01275-z.Peer-Reviewed Original ResearchConceptsCommunity-based participatory researchWound care nursesWound care suppliesNegative health outcomesLived experienceHarm reduction interventionsExperiences of peopleSemi-structured interviewsCare nursesHarm reduction organizationsHealth outcomesCare supplyReduction interventionsCommunity-BasedParticipatory researchHealthcare systemStigmatized peopleCommunity membersProgrammatic changesContent analysisHarmPWUOSafety concernsParticipantsRisk of robberyAcceptability and perceived feasibility of restroom motion sensors for overdose detection and response in public bathrooms: A cross-sectional study of businesses and community organizations
Rosen J, Koch R, Aslam R, Riendeau G, Krieger M, McKenzie M, Ramsey S, Green T, Rich J, Park J. Acceptability and perceived feasibility of restroom motion sensors for overdose detection and response in public bathrooms: A cross-sectional study of businesses and community organizations. Drug And Alcohol Dependence 2025, 274: 112788. PMID: 40651080, PMCID: PMC12335868, DOI: 10.1016/j.drugalcdep.2025.112788.Peer-Reviewed Original ResearchConceptsCross-sectional studyOverdose responseCommunity organizationsFisher's exact testBivariate correlationsResponse to overdoseTests of associationFatal overdose riskSolitary drug useStudy of businessStudy of employeesStaff perspectivesFisher's exact test of associationShift supervisorsStaff competenceLow awarenessOverdose riskPerceived valueStaffMotion sensorsSurvey managersDrug useBusinessWorkplaceOccupational contextA geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND)
Levengood T, Shaw L, Zang X, Schackman B, Walley A, Urquhart C, Green T, Chatterjee A, Marshall B, Morgan J. A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND). Drug And Alcohol Dependence 2025, 274: 112783. PMID: 40683013, PMCID: PMC12439111, DOI: 10.1016/j.drugalcdep.2025.112783.Peer-Reviewed Original ResearchA composite vignette: xylazine, infectious complications and the importance of community-based drug checking services
John L, Flint N, Piccolo F, Hill K, Anderson M, Townsend B, Fletcher M, Altomare-Jarczyk C, Silvia K, Green T, Thamattoor D, Bessette J, Thakarar K. A composite vignette: xylazine, infectious complications and the importance of community-based drug checking services. Therapeutic Advances In Infectious Disease 2025, 12: 20499361251365090. PMID: 40822666, PMCID: PMC12357011, DOI: 10.1177/20499361251365090.Peer-Reviewed Original ResearchStudy Protocol on Rapid Measurement of Novel Harm Reduction Housing on HIV Risk, Treatment Uptake, Drug Use, and Supply
Green T, Silcox J, Zaragoza S, Summers C, Rapisarda S, Kosakowski S, Rolles A, Chatterjee A, Walley A, Komaromy M, Case P. Study Protocol on Rapid Measurement of Novel Harm Reduction Housing on HIV Risk, Treatment Uptake, Drug Use, and Supply. Substance Abuse 2025, 46: 1058-1063. PMID: 40552912, DOI: 10.1177/29767342251341706.Peer-Reviewed Original ResearchHarm reduction servicesReduction servicesSocial cohesionDevelopment of social cohesionProvision of harm reduction servicesDrug useIndividual drug useUptake of servicesTreatment uptakeHIV riskOne-on-one interviewsMass relocationMixed-methods studyHousing environmentDrug-related outcomesHousingHealth outcomesCohort membersNeighborhoodDrug supplyResidentsRapid AssessmentServicesCohesionObservational cohort